Evidence map›Paper›PMID 35301473›Full record

ArticleNature chemistry2022

Reversible C-C bond formation using palladium catalysis.

Austin D Marchese, Bijan Mirabi, Colton E Johnson, Mark Lautens

Abstract read
PubMed Publisher
In one paragraph

Article in Nature chemistry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 43 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Ni-Catalyzed Oxygen Transfer from NJournal of the American Chemical Society · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Austin D Marchese *Department of Chemistry, Davenport Chemical Laboratories, University of Toronto, Toronto, Ontario, Canada.ORCID http://orcid.org/0000-0002-3090-2748
Bijan Mirabi *Department of Chemistry, Davenport Chemical Laboratories, University of Toronto, Toronto, Ontario, Canada.ORCID http://orcid.org/0000-0002-4852-3439
Colton E JohnsonDepartment of Chemistry, Davenport Chemical Laboratories, University of Toronto, Toronto, Ontario, Canada.ORCID http://orcid.org/0000-0002-0905-1248
Mark LautensDepartment of Chemistry, Davenport Chemical Laboratories, University of Toronto, Toronto, Ontario, Canada. mark.lautens@utoronto.ca.ORCID http://orcid.org/0000-0002-0179-2914
University of Toronto · CAToronto Public Health · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A widely appreciated principle is that all reactions are fundamentally reversible. Observing reversible transition metal-catalysed reactions, particularly those that include the cleavage of C-C bonds, is more challenging. The development of palladium- and nickel-catalysed carboiodination reactions afforded access to the cis and trans diastereomers of the iodo-dihydroisoquinolone products. Using these substrates, an extensive study investigating the reversibility of C-C bond formation using a simple palladium catalyst was undertaken. Herein we report a comprehensive investigation of reversible C-C bond formation using palladium catalysis employing diastereomeric neopentyl iodides as the starting point. It was shown that both diastereomers could be converted to a common product under identical catalytic conditions. A combination of experimental and computational studies were used to probe the operative mechanism. A variety of concepts key to understanding the process of reversible C-C bond formations were investigated, including the effect of electronic and steric parameters on the C-C bond-cleavage step.

Identifiers

PMID35301473
OpenAlexW4220744760

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.